Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Wood Website

Lauren V. Wood, M.D.

Selected Publications
1)  Castiello L, Sabatino M, Zhao Y, Tumaini B, Ren J, Ping J, Wang E, Wood LV, Marincola FM, Puri RK, Stroncek DF.
Quality controls in cellular immunotherapies: rapid assessment of clinical grade dendritic cells by gene expression profiling.
Mol. Ther. 21: 476-84, 2013. [Journal]
2)  Calabrese SK, Martin S, Wolters PL, Toledo-Tamula MA, Brennan TL, Wood LV.
Diagnosis disclosure, medication hiding, and medical functioning among perinatally infected, HIV-positive children and adolescents.
AIDS Care. 24: 1092-6, 2012. [Journal]
3)  Arlen PM, Wood LV.
Prostate cancer vaccines: moving therapeutic vaccination forward in the post-Provenge era.
Expert Rev Vaccines. 11: 287-302, 2012. [Journal]
4)  Berzofsky JA, Terabe M, Wood LV.
Strategies to use immune modulators in therapeutic vaccines against cancer.
Semin. Oncol. 39: 348-57, 2012. [Journal]
5)  Wood LV.
Why I voted "no" to Truvada PrEP.
Ann. Intern. Med. 157: 519-20, 2012. [Journal]
6)  Martin S, Elliott-DeSorbo DK, Calabrese S, Wolters PL, Roby G, Brennan T, Wood LV.
A comparison of adherence assessment methods utilized in the United States: perspectives of researchers, HIV-infected children, and their caregivers.
AIDS Patient Care STDS. 23: 593-601, 2009. [Journal]
7)  Wiener LS, Battles HB, Wood LV.
A longitudinal study of adolescents with perinatally or transfusion acquired HIV infection: sexual knowledge, risk reduction self-efficacy and sexual behavior.
AIDS and behavior. 11: 471-8, 2007. [Journal]
8)  Martin S, Elliott-DeSorbo DK, Wolters PL, Toledo-Tamula MA, Roby G, Zeichner S, Wood LV.
Patient, caregiver and regimen characteristics associated with adherence to highly active antiretroviral therapy among HIV-infected children and adolescents.
Pediatr. Infect. Dis. J. 26: 61-7, 2007. [Journal]
9)  Martin S, Wolters PL, Calabrese SK, Toledo-Tamula MA, Wood LV, Roby G, Elliott-Desorbo DK.
The Antiretroviral Regimen Complexity Index: A Novel Method of Quantifying Regimen Complexity.
J Acquir Immune Defic Syndr. 2007. [Journal]
10)  Bodaghi S, Wood LV, Roby G, Ryder C, Steinberg SM, Zheng ZM.
Could human papillomaviruses be spread through blood?.
J. Clin. Microbiol. 43: 5428-34, 2005. [Journal]
11)  Wiener L, Riekert K, Ryder C, Wood LV.
Assessing medication adherence in adolescents with HIV when electronic monitoring is not feasible.
AIDS Patient Care STDS. 18: 527-38, 2004. [Journal]
12)  Martin SC, Wolters PL, Klaas PA, Perez L, Wood LV.
Coping styles among families of children with HIV infection.
AIDS Care. 16: 283-92, 2004. [Journal]
13)  Taylor P, Worrell C, Steinberg SM, Hazra R, Jankelevich S, Wood LV, Zwerski S, Yarchoan R, Zeichner S.
Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens.
Pediatrics. 114: e235-42, 2004. [Journal]
14)  Srivastava S, Taylor P, Wood LV, Lee SS, Robinson MR.
Post-surgical scleritis associated with the ganciclovir implant.
Ophthalmic Surg Lasers Imaging. 35: 254-5, 2004. [Journal]
15)  Mukhopadhyay A, Wei B, Zullo SJ, Wood LV, Weiner H.
In vitro evidence of inhibition of mitochondrial protease processing by HIV-1 protease inhibitors in yeast: a possible contribution to lipodystrophy syndrome.
Mitochondrion. 1: 511-8, 2002. [Journal]
16)  Patsalides AD, Wood LV, Atac GK, Sandifer E, Butman JA, Patronas NJ.
Cerebrovascular disease in HIV-infected pediatric patients: neuroimaging findings.
AJR Am J Roentgenol. 179: 999-1003, 2002. [Journal]
17)  Chiou CC, Groll AH, Mavrogiorgos N, Wood LV, Walsh TJ.
Esophageal candidiasis in human immunodeficiency virus-infected pediatric patients after the introduction of highly active antiretroviral therapy.
Pediatr Infect Dis J. 21: 388-92, 2002. [Journal]
18)  Fry TJ, Connick E, Falloon J, Lederman MM, Liewehr DJ, Spritzler J, Steinberg SM, Wood LV, Yarchoan R, Zuckerman J, Landay A, Mackall CL.
A potential role for interleukin-7 in T-cell homeostasis.
Blood. 97: 2983-90, 2001. [Journal]
19)  Robinson MR, Salit RB, Bryant-Greenwood PK, Zeichner SL, Wood LV, Jaffe ES, van Waes C, Magrath IT.
Burkitt's/Burkitt's-like lymphoma presenting as bacterial sinusitis in two HIV-infected children.
AIDS Patient Care STDS. 15: 453-8, 2001. [Journal]
20)  Sei S, O'Neill DP, Stewart SK, Yang Q, Kumagai M, Boler AM, Adde MA, Zwerski SL, Wood LV, Venzon DJ, Magrath IT.
Increased level of stromal cell-derived factor-1 mRNA in peripheral blood mononuclear cells from children with AIDS-related lymphoma.
Cancer Res. 61: 5028-37, 2001. [Journal]
21)  Jankelevich S, Mueller BU, Mackall CL, Smith S, Zwerski S, Wood LV, Zeichner SL, Serchuck L, Steinberg SM, Nelson RP, Sleasman JW, Nguyen BY, Pizzo PA, Yarchoan R.
Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.
J Infect Dis. 183: 1116-20, 2001. [Journal]
22)  Sei S, Boler AM, Nguyen GT, Stewart SK, Yang QE, Edgerly M, Wood LV, Brouwers P, Venzon DJ.
Protective effect of CCR5 delta 32 heterozygosity is restricted by SDF-1 genotype in children with HIV-1 infection.
AIDS. 15: 1343-52, 2001. [Journal]
23)  Gonzalez CE, Adde M, Taylor P, Wood LV, Magrath I.
Impact of chemotherapy for AIDS-related malignancies in pediatric HIV disease.
Ann N Y Acad Sci. 918: 362-6, 2000. [Journal]
24)  Miller KD, Cameron M, Wood LV, Dalakas MC, Kovacs JA.
Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases.
Ann Intern Med. 133: 192-6, 2000. [Journal]
25)  Gonzalez CE, Samakoses R, Boler AM, Hill S, Wood LV.
Lymphoid interstitial pneumonitis in pediatric AIDS. Natural history of the disease.
Ann N Y Acad Sci. 918: 358-61, 2000. [Journal]
26)  Toro JR, Wood LV, Patel NK, Turner ML.
Topical cidofovir: a novel treatment for recalcitrant molluscum contagiosum in children infected with human immunodeficiency virus 1.
Arch Dermatol. 136: 983-5, 2000. [Journal]
Click Here to View Collapsed Bibliography.

This page was last updated on 2/27/2013.